Archive


Category: Digital Pathology

  • Tempus Launches Pathology-Driven AI Platform

    What You Should Know: – Tempus, a provider of artificial intelligence and precision medicine, today announced the launch of Edge, an innovative platform that allows pathologists to access developing AI models intended to identify specimens with potentially actionable biomarkers using a single hematoxylin and eosin stain (H&E) slide. – With access to over 50 petabytes of de-identified […]

  • Day 3 HIMSS Roundup: Glooko Acquires DIABNEXT, GE Healthcare/AliveCor Integration

    Venture Capital, Private Equity, Mergers & Acquisitions (M&A) Activity Glooko Acquires DIABNEXT® to Expand Diabetes Offerings in France Glooko, a leading provider of remote patient monitoring and data management solutions for diabetes and related chronic conditions, today announced the acquisition of DIABNEXT, a Paris-based company whose digital health platform helps people with diabetes better manage […]

  • Why Digital Pathology Platform Adoption Will Fail Without Intoperability

    Coleman Stavish, CTO, Proscia The global pandemic has cast a spotlight on the impact of digital transformation in healthcare. From ensuring access to care with telemedicine to accelerating vaccine development, technology has rapidly unlocked new sources of value for patients, providers, and researchers alike. While much of this has played out before our very eyes, […]

  • PathologyWatch Lands $25M for Digital Dermpath Lab Platform

    What You Should Know:  – Digital lab and pathology platform PathologyWatch, today announced $25 million in Series B funding with participation from Ceros Capital Markets, Rock Creek Capital,Springtide Capital, Spark Growth Ventures, Blueprint Health, Blackbrook Management Group, and existing investors. – AI in diagnostic services grew by 80% in 2020, largely in response to the […]

  • HLTH21: Roche, Ibex Medical Partner to Develop AI-Powered Digital Pathology Apps

    What You Should Know:  – Ibex Medical Analytics, the pioneer in AI-based cancer diagnostics, today announced that it has signed a deal with Roche, the world’s largest biotech company and global pioneer in pharmaceuticals and diagnostics. Ibex will be integrating its Galen™ platform into Roche’s uPath enterprise cloud software in order to help pathologists to […]

  • Philips, Ibex Medical Analytics Partner on AI-Powered Digital Pathology Adoption

    What You Should Know: – Philips and Ibex Medical Analytics announced a strategic partnership to globally commercialize clinically proven, AI-powered digital pathology solutions. The collaboration further cements Philips’ commitment to integrated diagnostics providing a clear path to precision diagnosis. – The trend towards centralized pathology labs, the global shortage of trained pathologists, and increasing demands on histopathology […]

  • Proscia Secures $23M for AI-Enabled Digital Pathology Solutions

    What You Should Know: – Proscia secures $23M in Series B funding led by Scale Venture Partners for its AI-enabled digital pathology solutions. – Proscia will use the funding to expand its AI application portfolio, boost commercial expansion, and advance its regulatory strategy to secure FDA approval. Proscia, a Philadelphia-based provider of digital and computational […]

  • JPC Taps Proscia to Modernize World’s Largest Human Tissue Repository

    What You Should Know: – The U.S. government’s Joint Pathology Center, which houses the world’s largest human tissue repository, today announced that Proscia, a leading digital and AI pathology company, will provide end-to-end modernization of JPC’s pathology operations. – The multi-phase project will digitize the world’s largest human pathology specimen repository in order to enhance […]

  • Insights+ Interview: Paige’s CEO, Leo Grady Shares Insights on its Series B Funding and the FDA’s 510(k) Clearance for FullFocus Viewer

    Paige is a global digital pathology founded in 2017 by Thomas Fuchs, Dr. Sc., and colleagues from Memorial Sloan Kettering Cancer Center. The company involves computational pathology products that are targeted for patients and their care teams for effective, more informed treatment decisions. Paige has developed a platform to deliver novel technology to pathologists to […]

  • Paige Lands Additional $15M for AI-Native Digital Pathology Ecosystem

    What You Should Know: – Paige secures an additional $15M from Goldman Sachs for a total Series B funding round of $70M for its AI-native digital pathology ecosystem. – The company’s continued product portfolio of innovation in telepathology and digital diagnostics accelerated by further investment. Paige, an NYC-based leader in computational pathology transforming the diagnosis […]